Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lisata Therapeutics (LSTA) Operating Margin (2016 - 2025)

Lisata Therapeutics' Operating Margin history spans 11 years, with the latest figure at 3079.0% for Q4 2025.

  • For Q4 2025, Operating Margin fell 258410.0% year-over-year to 3079.0%; the TTM value through Dec 2025 reached 10710.59%, down 846969.0%, while the annual FY2025 figure was 10711.18%, 847028.0% down from the prior year.
  • Operating Margin reached 3079.0% in Q4 2025 per LSTA's latest filing, up from 6954.29% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 494.9% in Q4 2024 to a low of 6954.29% in Q2 2025.